Skip to main content
  • Original Research Article
  • Open access
  • Published:

Gallstones in Egyptian infants and children: risk factors, complications and outcome: a single center experience

Abstract

Background

The widespread use of abdominal ultrasonography in children documented increased detection rate of gallstones. The aim of this study was to assess the possible risk factors of gallstones and to detect the complication rate and outcome of the disease in Egyptian infants and children from a hepatologist perspective. This prospective study included 35 cases, with ultrasound-detected gallstones, who presented to the Pediatric Hepatology Unit from July 2015 to October 2017. All patients were initially evaluated by full history, general and abdominal examination, laboratory assessment, and ultrasound findings to detect possible risk factors of gallstones. Management approach was individualized for each patient according to his/her condition, and the patients were followed up at 3 months interval.

Results

The patients’ ages ranged from 3.5 months up to 17 years. The median age of gallstone detection was 2 years. Gallstones were symptomatic in 62.9% with abdominal pain in 51.4%. Complications in the form of choledocholithiasis were detected in 7 patients (20%). Laparoscopic cholecystectomy was done for 7 patients while conservative management was applied for 24 patients. Complete resolution occurred in 8.3% and partial resolution in 33.3%. Chronic hemolytic anemia was the most commonly identified risk factor for gallstones. Patients needed surgical intervention had significant higher serum cholesterol and LDL levels (P = 0.006 and P = 0.002 respectively).

Conclusion

Risk factors for gallstones could be identified in most of pediatric cases. Symptomatic presentation is common among the pediatric population. Conservative management is recommended for asymptomatic cases of gallstones in children. Laparoscopic cholecystectomy is a safe and recommended procedure for complicated and symptomatic cases of gallstones.

Background

The prevalence of gallstones in the pediatric population has been reported to be uncommon with estimated overall prevalence of 0.13 to 1.9%. However, the increased use of abdominal ultrasonography (US) in recent years has led to increased rate of detection of gallstones [1].

Many etiological factors have been associated with gallstones in children. Chronic hemolytic diseases are considered the most common cause. Other risk factors include liver cirrhosis, chronic cholestasis, total parenteral nutrition, and ileal diseases such as ileal resection, ileal Crohn’s disease, cystic fibrosis, prolonged use of high-dose ceftriaxone, cancer therapy, family history, obesity, and congenital anomalies in the GB [2].

Little information is available about the management of this disorder in childhood as diagnostic approach, and therapeutic strategies are extremely heterogeneous. For symptomatic cases, cholecystectomy is curative, and laparoscopic cholecystectomy has been proven to be safe and efficient [3]. Asymptomatic patients show a more difficult management dilemma. Considering the low rate of complications detected by many studies, expectant management with periodical clinical and US follow-up is recommended. Spontaneous resolution of gallstones was observed in many cases [4]. Elective cholecystectomy is recommended for children with chronic hemolytic anemia at the time of gallstone diagnosis, before symptoms, or complications develop [5].

The aim of this study was to assess the possible risk factors of gallstones and to detect the complication rate and outcome of the disease in infants and children.

Methods

This prospective study was conducted at the Pediatric Hepatology Unit during the time period from July 2015 to October 2017. All cases below 18 years of age of both sexes with US detected gallstones were enrolled in this study. The study was approved by the institutional ethical committee of the Pediatrics Department. A written informed consent was taken from patients’ guardians.

Patient evaluation

Initial diagnosis

All patients were evaluated in terms of age, sex, presenting symptoms (typical biliary colic, nonspecific abdominal pain, nausea, vomiting or fatty food intolerance, and symptoms of complications as fever or jaundice), precipitating risk factor for gallstone, and other accompanying diseases.

Laboratory assessment

Complete blood count (CBC) and liver function tests, hemolytic profile (reticulocytes, osmotic fragility, quantitative glucose 6 phosphate dehydrogenase (G6PD) measurement, hemoglobin electrophoresis, direct coombs test), lipid profile (serum cholesterol (LDL-HDL-VLDL) and serum triglycerides), and sweat chloride test if cystic fibrosis was suspected (multisystem presentations: pulmonary, gastrointestinal, and others as dehydration and metabolic alkalosis), and serum amylase and lipase if pancreatitis is suspected.

Radiological assessment

Abdominal US, endoscopic retrograde cholangiopancreatography (ERCP) in cases of choledocholithiasis, magnetic resonance cholangiopancreatography (MRCP) is done when choledocholithiasis is suspected, and ERCP cannot be done for technical consideration as young age (age less than 2 years) and in cases with US documented CBD dilatation.

Management approach

Conservative management

For asymptomatic patients with no complications, it involved periodic clinical and US follow up at 3-month intervals for at least 1 year.

Medical dissolution of gallstones by Ursodeoxycholic Acid (UDCA)

A trial of oral UDCA dissolution of stones was applied at a dose of 15 mg/kg/day for those patients with symptomatic uncomplicated gallstones with periodic clinical and ultrasound follow-up for symptoms’ improvement and/or stone dissolution every 3 months. Symptomatic uncomplicated gallstones were defined as the presence of biliary colic in the form of significant abdominal pain in the absence of complications as acute or chronic cholecystitis, ascending cholangitis, common bile duct stones, or pancreatitis.

ERCP

ERCP is for patients with choledocholithiasis.

Laparoscopic cholecystectomy (LC) is for (1) patients with complicated gallstones as cases with choledocholithiasis, cholecystitis, or pancreatitis, (2) patients with symptomatic gallstones not improving on UDCA, and (3) patients with chronic hemolytic anemia.

Patient follow-up

Patients who were not indicated for surgery were followed every 3 months with clinical, laboratory and ultrasound assessments. Resolution of gallstones was based on ultrasonographic evidence of absence of gallbladder and bile duct stones.

Statistical analysis

Data was analyzed by the Statistical Package of Social Science Software program, version 23. Data was presented using mean, standard deviation (SD) for homogenous quantitative variables, median and interquartile range (IQR) for quantitative variables with non-homogenous distribution, and frequency and percentage for qualitative ones. Comparison between groups was performed using Mann-Whitney test for quantitative variables and chi-square and Fisher’s exact test for qualitative ones. P values less than 0.05 were considered statistically significant.

Results

Thirty-five children with gallstones were included; 54.3% were males. Their age ranged from 3.5 months to 17 years. Out of these 35 patients, 18 patients (51.4%) were below 2 years of age at the time of discovery of gallstones (infantile group), while 17 (48.6%) had their discovery onset beyond 2 years.

They were referred to hepatology clinic because of accidently detected gallstones in US done for other purposes in 25 cases (71.4%), jaundice in 7 (20%), and elevated liver enzymes in 3 (8.6%). Patients with US detected gallstones were referred from everywhere including general outpatient clinics as well as hematology and neonatology units. US was repeated in hepatology clinic for confirmation and for detailed sonographic examination. Twenty-two (62.9%) patients had symptomatic gallstones: abdominal pain as the most common presentation (51.4%), jaundice (28.6%), vomiting, nausea, and fatty food intolerance in 25.7%, 11.4%, and 14.3% respectively. Eight patients (22.9%) showed elevated total bilirubin; all with elevated direct fraction except one who had β-thalassemia major, in whom indirect bilirubin was elevated. The seven patients with direct hyperbilirubinemia included 6 patients with choledocholithiasis, and one patient had cholestasis with normal GGT.

Lipid profile showed abnormal results in 7 cases. Three patients (8.6%) had hypercholesterolemia, and 4 patients had elevated triglycerides level.

Abdominal US done by 2 operators revealed single gallstones in 17 cases (48.6%) and multiple gallstones in 18 cases (51.4%). Size of stones ranged from 0.3 to 1.6 cm with median 0.6 cm with IQR (0.4–0.8). Biliary sludge with gallstones was evident in 9 cases (25.7%) while common bile duct (CBD) stones were detected in 6 cases (17.1%); 5 (14.3%) of them showed CBD and biliary radicles dilatation.

Possible etiology could be reached in 25 patients where hemolytic anemia was the most common identified diagnosis (Fig. 1). History of dehydration and neonatal intensive care admission were more prevalent among the infantile group but with no statistical significance. Duration of NICU admission was significantly longer among patients with multiple stones (P = 0.044) compared to those with single stone.

Fig. 1
figure 1

Possible etiology of gallstones in the study patients

The management plan was individualized for each patient (Fig. 2). For cases with complicated gallstones in the form of choledocholithiasis, cholecystectomy was performed while conservative management was planned for the other 28 cases (80%). The medical treatment was offered to non-hemolytic cases with patent cystic, and common bile duct with stone size was less than 2 cm. LC was offered for patients with hemolytic anemia, before symptoms or complications developed, but unfortunately, it was not performed except in complicated cases.

Fig. 2
figure 2

The management plan of the 35 children with gallstones

LC was done for 7 patients (20%): 6 of them had choledocholithiasis while one of the patients with choledocholithiasis dropped out of the study. A patient was indicated for LC because of attacks of agonizing abdominal pain after 3 months of conservative management with no improvement (Fig. 2).

For the 7 patients with choledocholithiasis, MRCP was done for 5 patients, and ERCP was done for 2 patients. For the 2 patients who have done ERCP, one patient was 9 years old, and ERCP showed mild dilated intrahepatic biliary radicles (IHBR) and CBD, sphincterotomy with dormia basket was done, and multiple gravels were removed. The other patient was 5 years old; ERCP revealed normal CBD and IHBR with multiple stones, sphincterotomy was done, and stones were removed. Regarding the other 5 patients, one patient was dropped out, while the other 4 patients had spontaneous relief of obstructive jaundice. LC was then performed for the 6 cases. Histopathological analysis of the removed gall bladder in this study was available in 6 cases and revealed chronic cholecystitis in all of them (100%): none had papillomatosis or adenoma of the gall bladder.

For the 28 patients (80%) who were subjected to conservative management, 3 patients dropped out of follow-up, and one (an infant with cerebral palsy) died 1 month after enrollment due to septicemia. The other 24 patients were followed up for 8 to 34 months with a median of 14 months.

Twelve patients (34.3%) with symptomatic gallstones were managed conservatively with UDCA for a period ranging from 3 to 24 months and a median of 4.5 months. Follow-up showed complete resolution of gallstones in 2 patients (8.3%). One of them was a 3-year-old boy with congenital adrenal hyperplasia who showed decrease in number of stones from 2 stones to a single stone after 6 months of therapy; however, this patient showed spontaneous resolution of this remaining gallstone after another 6 months without UDCA administration. Five patients (20.8%) showed partial improvement, evident with disappearance of symptoms; one patient (4.2%) showed partial sonographic improvement while 2 patients (8.3%) showed partial clinical and sonographic improvement (Fig. 2). Sonographic improvement was based on decreased number of stones and/or disappearance of biliary sludge.

Based on their management strategy, patients were classified into two groups: medical and surgical. Those who needed LC were significantly older at the onset of stones (P = 0.005). In addition, their serum cholesterol and LDL levels were significantly higher than those who subjected to medical management (Table 1).

Table 1 Risk factors of gallstones and laboratory investigations among medical and surgical patients

Patients were also divided based on symptomatology at the time of initial diagnosis into two groups: symptomatic and asymptomatic. G6PD deficiency was significantly higher in the asymptomatic group. Symptomatic cases had significant lower RBC count, hemoglobin, and hematocrit than asymptomatic cases (Table 2).

Table 2 Risk factors of gallstones and complications in symptomatic and asymptomatic patients

Discussion

Pediatric cholelithiasis is known to be uncommon. However, recent series documented increased detection rate of gallstones in the pediatric age group [1]. Many risk factors have been described for the development of gallstones in children as hemolytic disorders, prematurity, parenteral nutrition, chronic hepatobiliary diseases, cystic fibrosis, genetic factors, sepsis, ileal diseases, obesity, ceftriaxone use, and abdominal or cardiac surgeries [6]. Idiopathic gallstones, with no identifiable risk factors, have been reported in the literature in the range of 23.2–52.5% [2, 7, 8]. This is close to the current study where no risk factors were identified in 28.6%of cases.

Twenty to 40% of all pediatric gallstone disease can be attributed to hemolytic diseases [9]. Recent studies demonstrated hemolytic diseases in 21.6% and in 11.8% of cases [10, 11]. In the current study, hemolytic anemia was identified as a risk factor in 34.3%. G6PD deficiency was identified as a risk factor in 9 cases (25.7%); this high percentage may be explained by the high prevalence of G6PD deficiency in Egypt as reported by Abo Elella et al. in 2017 who estimated an overall prevalence of G6PD deficiency of 4.3% among Egyptian neonates [12].

Therapy with ceftriaxone was identified as a risk factor in 17.1% of cases, in agreement with literature where ceftriaxone use was responsible for 6% and 27.3% of cases of gallstones [2, 13].

Chronic biliary disease in the form of cholestasis was present in 8.6% of our cases, which is close to the results of Dooki and Norouzi (2013) and Della Corte et al (2008) studies (7.5% and 5% respectively) [2, 13]. It is known that patients with chronic cholestasis especially those with progressive familial intrahepatic cholestasis (PFIC) are prone to cholelithiasis. This is attributed to impaired bile acid secretory function and supersaturation of bile with cholesterol [14]. The three cholestatic patients in this study had normal GGT cholestasis; however, the unavailable genetic analysis in Egypt limited the ability to finally diagnose their specific conditions. These patients might have had PFIC 1 or 2.

Unlike adults, children are likely to be symptomatic [8]. Our cases showed symptomatic presentation in 62.9%, which is comparable to other studies [2, 9, 10]. On the other hand, the study of Kirsaclioglu et al. [11] showed that symptomatic patients were significantly older than asymptomatic patients, and abdominal pain was the most frequent symptom [11]. Our cases also showed abdominal pain to be the most common symptom in 51.4%.

Complications were documented in 20% of our cases, which is close to the literature, where they were reported in about 7–20% of cases [6]. While some older studies reported pancreatitis as the most common complication [15, 16], recent studies reported cholecystitis and choledocholithiasis to be more common [1, 11, 17]. Our study showed choledocholithiasis to be more common; meanwhile, none of our cases showed pancreatitis or acute cholecystitis. The relatively high complication rate seen in our study group could be explained by the nature of our hospital being a tertiary referral hospital. Severe and complicated cases are commonly referred to our institution, while uncomplicated cases can be managed conservatively in secondary referral centers.

In children, cholecystectomy is recommended for symptomatic and complicated gallstones. It is also recommended for asymptomatic gallstones with chronic hemolytic anemia and asymptomatic large sized gallstones (> 2 cm) for the risk of gallbladder carcinoma [4]. Otherwise, expectant management with periodic clinical and sonographic assessment appears more appropriate [4]. LC was done for 7 of our patients: 6 of them because of choledocholithiasis and one for symptomatic gallstone with agonizing typical right upper quadrant pain. Hajong et al. in 2013 reported 15 non-hemolytic cases of gallstones managed by LC; 80% were symptomatic, and 13.3% were asymptomatic while 6.7% had complicated gallstone in the form of pancreatitis [18]. Another study showed that primary indications for surgery in pediatric population were symptomatic cholelithiasis (53%), choledocholithiasis (28%), and biliary dyskinesia (16%) [9].

Histopathological analysis of the removed gall bladder (GB) in this study was available in 6 cases and revealed chronic cholecystitis in all of them (100%); none had papillomatosis or adenoma of GB. This is comparable to the results of Kim et al. study, who showed that, in 24 cases for whom cholecystectomy was performed, histopathology of most cases revealed chronic cholecystitis [19]. On the other side, the removed gallbladders in Della Corte et al. study revealed chronic cholecystitis in 84.6%, papillomatosis in 5.1%, adenoma in 2.6%, and normal GB in 7.7% [2].

Eighty percent of our cases were managed conservatively, with periodic clinical, laboratory and US follow-up for 8 to 34 months. None of them developed complications, while 2 cases showed complete spontaneous resolution of gallstones, and 8 cases showed resolution of symptoms and/or sonographic improvement. This may justify the conservative management for uncomplicated cases of gallstones in pediatric population, especially in infants. Jeanty et al., who performed their study on infantile cholelithiasis, observed complete resolution of stones in 25% of the cases [20], while Gokce et al. [21] reported spontaneous complete resolution in 50% of infantile cases and 19.8% in older children [1]. This was higher than the resolution rate observed in the current study.

Limitations of this study include the small sample size and the short duration of follow-up in some patients. Moreover, as the study was conducted in a tertiary care unit, many uncomplicated cases may be diagnosed and managed in other centers without referral to our unit, which may explain the higher rate of complications at presentation of our cases.

The strength of this study is that it is the first study to evaluate gallstones among infants and children in Egypt. The absence of a national screening program for G6PD deficiency and other hemolytic anemias, together with high incidence of consanguineous marriages, raises the risk of childhood gallstones in Egypt.

Conclusion

Risk factors for gallstones could be identified in most of pediatric cases. Symptomatic presentation is common among the pediatric population. Conservative management is supported for asymptomatic cases. Laparoscopic cholecystectomy is a safe and recommended procedure for complicated and symptomatic cases.

Availability of data and materials

Not applicable

Abbreviations

ALT:

Alanine aminotransferase

AST:

Aspartate aminotransferase

CBC:

Complete blood count

CBD:

Common bile duct

PFIC:

Progressive familial intrahepatic cholestasis

PT:

Prothrombin time

SD:

Standard deviation

IHBR:

Intrahepatic biliary radicles

INR:

International normalized ratio

IQR:

Interquartile range

LC:

Laparoscopic cholecystectomy

LDL:

Low-density lipoprotein cholesterol

PT:

Prothrombin time

SD:

Standard deviation

UDCA:

Ursodeoxycholic acid

US:

Ultrasonography

References

  1. Gupta SK, Shukla VK (2004) Silent gallstones: a therapeutic dilemma. Trop Gastroenterol 25:65–68

    CAS  PubMed  Google Scholar 

  2. Della Corte C, Falchetti D, Nebbia G, Calacoci M, Pastore M, Francavilla R et al (2008) Management of cholelithiasis in Italian children: a national multicenter study. World J Gastroenterol 14:1383–1388

    Article  Google Scholar 

  3. Garey CL, Laituri CA, Keckler SJ, Ostlie DJ, Stagg HW, Little DC et al (2010) Laparoscopic cholecystectomy in obese and non-obese children. J Surg Res 163:299–302

    Article  Google Scholar 

  4. Dipaola F, Heubi J. Disease of gallbladder in infancy, childhood, and adolescence. In: Suchy F, Sokol R, Balistreri W, editors. Liver Disease in Children, 4th edition. Cambridge university press; 2014: 247-264.

  5. Alonso M (2004) Gall bladder abnormalities in children with sickle cell disease: management with laparoscopic cholecystectomy. J Pediatr 145:580–581

    Article  Google Scholar 

  6. Svensson J, Makin E (2012) Gallstone disease in children. Semin Pediatr Surg 21:255–265

    Article  Google Scholar 

  7. Wesdorp I, Bosman D, de Graaff A, Aronson D, van der Blij F, Taminiau J (2000) Clinical presentations and predisposing factors of cholelithiasis and sludge in children. J Pediatr Gastroenterol Nutr 31:411–417

    Article  CAS  Google Scholar 

  8. Bogueu C, Murphy A, Gerstle J, Moineddin R, Daneman A (2010) Risk factors, complications, and outcome of gallstones in children: a single center review. J Pediatr Gastroenterol Nutr 50:303–308

    Article  Google Scholar 

  9. Mehta S, Lopez M, Chumpitazi B, Mazziotti M, Brandt M, Fishman D (2012) Clinical characteristics and risk factors for symptomatic pediatric gallbladder disease. Pediatrics 129:82–88

    Article  Google Scholar 

  10. Sahin Y, Sahin D, Bulut F, Turkut A, Goktepe A (2014) Gallstone in children: aretrospective study of 37 cases in southeast of Turkey. IJSR 3:398–402

    Google Scholar 

  11. Kirsaclioglu C, Çakır B, Bayram G, Akbıyık F, Işık P, Tunç B (2016) Risk factors, complications and outcome of cholelithiasis in children: a retrospective, single-centre review. J Paediatr Child Health 52:944–949

    Article  Google Scholar 

  12. Abo Elella S, Tawfik M, Barseem N, Moustafa W (2017) Prevalence of glucose-6-phosphate dehydrogenase deficiency in neonates in Egypt. Ann Saudi Med 37:362–365

    Article  Google Scholar 

  13. Dooki M, Norouzi A (2013) Cholelithiasis in childhood: a Cohort study in North of Iran. Iran J Pediatr 23:588–592

    PubMed  PubMed Central  Google Scholar 

  14. Suchy F, Sundaram S, Shneider B. Familial hepatocellular cholestasis. In: Suchy F, Sokol R, Balistreri W, editors. Liver Disease in Children, 4th edition. Cambridge university press; 2014:199- 215.

  15. Reif S, Sloven D, Lebenthal E. Gallstones in children: characterization by age, etiology and outcome. Am J Dis Child 1991;145: 105- 108. PMID: 1898681

  16. Lugo-Vicente HL (1997) Trends in management of gallbladder disorders in children. Pediatr Surg Int 12:348–352

    Article  CAS  Google Scholar 

  17. Sarrami M, Ridley W, Nightingale S, Wright T, Kumar R (2019) Adolescent gallstones—need for early intervention in symptomatic idiopathic gallstones. Pediatr Surg Int 35:569–574

    Article  CAS  Google Scholar 

  18. Hajong R, Tongper D, Khariong P, Mibang N (2013) Non-hemolytic childhood cholelithiasis managed laparoscopically: a report 1f 15 cases. IOSR-JDMS 7:31–34

    Article  Google Scholar 

  19. Kim H, Kim S, Cho Y (2015) Pediatric cholecystectomy: clinical significance of cases unrelated to hematologic disorders. Pediatr Gastroenterol Hepatol Nutr 2:115–120

    Article  Google Scholar 

  20. Jeanty C, Derderian S, Courtier J, Hirose S (2015) Clinical management of infantile cholelithiasis. J Pediatr Surg 50:1289–1292

    Article  Google Scholar 

  21. Gokce S, Yıldırım M, Erdoğan D (2014) A retrospective review of children with gallstone: Single-center experience from Central Anatolia. Turk J Gastroenterol; 25:46–53.

Download references

Acknowledgements

Not applicable

Funding

This study has no funding source.

Author information

Authors and Affiliations

Authors

Contributions

EM was responsible for constructing the research hypothesis and planning the methodology. EA was responsible for patients’ inclusion and follow-up. ME collected and tabulated the data. AR was responsible for interpretation and presentation of the results. AM and EM wrote the manuscript. ME and EA revised the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to A. Enayet.

Ethics declarations

Ethics approval and consent to participate

This study was performed at Cairo University Hospitals, Cairo, Egypt, after approval of the ethical committee of Kasr Alainy Medical School, Cairo University.Ethical committee number: I-071014.

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Written informed consent was obtained from all patients’ guardians for being included in the study.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Enayet, A., Afifi, R.A., Mogahed, E.A. et al. Gallstones in Egyptian infants and children: risk factors, complications and outcome: a single center experience. Egypt Liver Journal 10, 31 (2020). https://doi.org/10.1186/s43066-020-00037-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43066-020-00037-9

Keywords